NCT00443950View on ClinicalTrials.gov

Study Evaluating the Efficacy and Safety of Etanercept in Chinese Subjects With Rheumatoid Arthritis

PHASE3CompletedINTERVENTIONAL
Enrollment

150

Participants

Timeline

Start Date

June 30, 2006

Study Completion Date

July 31, 2007

Conditions
Arthritis, Rheumatoid
Interventions
DRUG

Etanercept

Trial Locations (6)

100029

Beijing

100044

Beijing

100853

Beijing

200001

Shanghai

510275

Guangzhou

710032

Xi'an

All Listed Sponsors
lead

Wyeth is now a wholly owned subsidiary of Pfizer

INDUSTRY

NCT00443950 - Study Evaluating the Efficacy and Safety of Etanercept in Chinese Subjects With Rheumatoid Arthritis | Biotech Hunter | Biotech Hunter